Indolent Non-Hodgkin's Lymphomas Completed Phase 3 Trials for Cyclosporine (DB00091)

Also known as: Indolent Non-Hodgkin Lymphoma / Indolent Non-Hodgkin's Lymphoma

IndicationStatusPhase
DBCOND0061053 (Indolent Non-Hodgkin's Lymphomas)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01231412Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell TransplantTreatment